Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K33/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2020/136276DRY POWDER INHALATION FORMULATION AND ITS USE FOR THE THERAPEUTIC TREATMENT OF LUNGS
WO 02.07.2020
Int.Class A61K 38/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
28Insulins
Appl.No PCT/EP2019/087122 Applicant UNIVERSITÉ LIBRE DE BRUXELLES Inventor AMIGHI, Karim
Dry powder inhalation formulation comprising at least one API and a lipid matrix comprising at least one triglyceride chosen in the group consisting of monohydroxystearin, dihydroxystearin, trihydroxystearin and their mixture and its manufacturing method.
2.WO/2020/138036EFFERVESCENT ORAL TABLET IN SEALED CONTAINER
WO 02.07.2020
Int.Class A61K 31/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
Appl.No PCT/JP2019/050523 Applicant KAO CORPORATION Inventor SAITO, Takuya
This effervescent oral table in a sealed container contains the components (A) to (C) indicated below. The ratio (HB)/(HA) of the number of moles of acid groups of the component (B) to the number of moles of acid groups of the component (A) when the component (B) comprises only citric acid or a salt thereof or comprises only ascorbic acid or a salt thereof is 0.1-4.0, and said ratio is 0.05-5.5 when the component (B) comprises a combination of citric acid or a salt thereof and ascorbic acid or a salt thereof. In addition, the ratio [(HA)+(HB)]/(C) of the total number of moles of acid groups of the components (A) and (B) to the number of moles of the component (C) is 0.7-1.35. Component (A): tartaric acid or a salt thereof, 0.1-22 mass%. Component (B): citric acid, ascorbic acid, or a salt thereof. Component (C): a carbonate, 14-30 mass%.
3.WO/2020/133198STABILIZED AQUEOUS HEMOFILTRATION BASIC SOLUTION, DIALYSIS SOLUTION AND CORRESPONDING KIT
WO 02.07.2020
Int.Class A61K 33/42
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
42Phosphorus; Compounds thereof
Appl.No PCT/CN2018/124806 Applicant FRESENIUS MEDICAL CARE R&D (SHANGHAI) CO., LTD. Inventor LIU, Taoe
A stabilized aqueous hemofiltration basic solution for preparation of a hemofiltration solution or medical substitution fluid comprising · 69-128 mmol/L Sodium ions, · 0-4.8 mmol/L Potassium ions, · 1.1-2.7 mmol/L Calcium ions, · 0.27-1.6 mmol/L Magnesium ions, · 96-128 mmol/L Chloride ions, · 0-27 mmol/L Glucose, and · 0.1-0.3 mmol/L Phosphate ions. A dialysis solution and a corresponding kit for preparing an aqueous hemofiltration solution or medical substitution fluid are provided; it will be more safe and convenient than current clinical practice.
4.WO/2020/139689COMPOSITIONS AND METHODS FOR TREATING BURNS, WOUNDS, AND SKIN DISORDERS
WO 02.07.2020
Int.Class A61K 31/718
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716Glucans
718Starch or degraded starch, e.g. amylose, amylopectin
Appl.No PCT/US2019/067432 Applicant KIM, Katherine, Echo Inventor KIM, Katherine, Echo
The present invention provides compositions and methods for treating burns, wounds, and skin disorders. The compositions are based on the blackened, milled powder, i.e. ash, derived from processing the tuberous portion of a plant, such as the potato, at a high temperature.
5.WO/2020/135920KIT FOR INHALED CHEMOTHERAPY, AND TREATMENT OF LUNG CANCER WITH SAID KIT
WO 02.07.2020
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/EP2018/097140 Applicant UNIVERSITÉ LIBRE DE BRUXELLES Inventor AMIGHI, Karim
Kit for an inhaled chemotherapy comprising a series of single hermetically packaged therapeutic doses of a dry powder for inhalation containing at least one anti-neoplastic agent chosen in the group consisting of platinum drugs with a lipid matrix and a PEGylated excipient and a series of disposable dry powder inhaler devices, its use and method of treatment of cancer lungs with said kit.
6.WO/2020/137045SHEET FOR HYDROGEN-RICH WATER
WO 02.07.2020
Int.Class A61K 8/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
19containing inorganic ingredients
Appl.No PCT/JP2019/037250 Applicant NIHON TRIM CO., LTD. Inventor MORISAWA Shinkatsu
A sheet for hydrogen-rich water, which is configured such that: a sheet main body (12) is formed of cellulose fibers that are composed of cellulose nanofibers, while being impregnated or coated with an electrolyzed hydrogen-rich water (13); the electrolyzed hydrogen-rich water (13) contains platinum nanocolloids to which atomic hydrogen adsorbs; and the platinum nanocolloids are bonded to the cellulose nanofibers upon impregnation or application of the electrolyzed hydrogen-rich water (13).
7.WO/2020/138422HYDROXYAPATITE PARTICULATE
WO 02.07.2020
Int.Class C01B 25/32
CCHEMISTRY; METALLURGY
01INORGANIC CHEMISTRY
BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF
25Phosphorus; Compounds thereof
16Oxyacids of phosphorus; Salts thereof
26Phosphates
32Phosphates of magnesium, calcium, strontium, or barium
Appl.No PCT/JP2019/051429 Applicant SHIRAISHI CALCIUM(SINGAPORE) PTE., LTD. Inventor KISHI, Kohei
The present invention addresses the problem of providing a particle which has the ability to seal dentinal tubules and exhibits excellent adhesion in dentinal tubules. In order to solve the problem, provided is a hydroxyapatite particulate which is an aggregate of particles, wherein the ratio of a diffraction peak intensity around 2θ = 32° to a diffraction peak intensity around 2θ = 26° in an X-ray diffraction pattern measured using a CuKα ray is 0.8-1.6.
8.WO/2020/136272KIT FOR INHALED CHEMOTHERAPY, AND TREATMENT OF LUNG CANCER WITH SAID KIT
WO 02.07.2020
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/EP2019/087118 Applicant UNIVERSITÉ LIBRE DE BRUXELLES Inventor AMIGHI, Karim
Kit for an inhaled chemotherapy comprising a series of single hermetically packaged therapeutic doses of a dry powder for inhalation containing at least one anti-neoplastic agent chosen in the group consisting of platinum drugs with a lipid matrix and a PEGylated excipient and a series of disposable dry powder inhaler devices, its use and method of treatment of cancer lungs with said kit.
9.WO/2020/139901A BONE REGENERATION MATERIAL HAVING A COTTON-WOOL LIKE STRUCTURE FORMED OF A PLURALITY OF ELECTROSPUN FIBERS
WO 02.07.2020
Int.Class A61L 24/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
24Surgical adhesives or cements; Adhesives for colostomy devices
02containing inorganic materials
Appl.No PCT/US2019/068509 Applicant ORTHOREBIRTH CO., LTD. Inventor TAIRA, Hiroyuki
A bone regeneration material has a cotton-wool like structure formed of a plurality of electrospun fibers that contain bound BMP-2 through β-TCP binding peptide. The electrospun biodegradable fiber contains 25-65 vol% of β-TCP particles distributed in the fiber such that a portion of the β-TCP particles is exposed on a surface of the electrospun fiber and the remaining portion of the β-TCP particles is buried in the fiber. β-TCP binding peptides that are fused with BMP-2 are bound to the β-TCP particles so that BMP-2 is tethered to β-TCP particles on the surface of the fibers. Upon implantation of the bone regeneration material in a bone defect site of a human body, BMP-2 that are tethered to β-TCP particles on the surface of the bone regeneration material promotes proliferation and differentiation of cells at the bone defect site.
10.WO/2020/140029NUCLEOPHILIC CHEMICALS USEFUL IN THE TREATMENT OF CISPLATIN-INDUCED SENSORY NEUROPATHY AND OTOTOXICITY
WO 02.07.2020
Int.Class A61K 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
12Ketones
Appl.No PCT/US2019/068734 Applicant MONTEFIORE MEDICAL CENTER Inventor LOPACHIN, Richard, M.
Methods and compositions are disclosed for reducing neuropathy or ototoxicity associated with chemotherapeutic agents by administering one or more enol compounds to a subject.